BRIEF

on DIAGNOSTIC MEDICAL (EPA:ALDMS)

DMS Group Achieves European MDR Certification for STRATOS Densitometers

Stock price chart of DIAGNOSTIC MEDICAL (EPA:ALDMS) showing fluctuations.

Diagnostic Medical Systems, specializing in digital radiology and bone densitometry, has obtained EU MDR certification for its STRATOS and STRATOS DR bone densitometers. This compliance confirms adherence to the latest safety, clinical performance, and quality standards. As the sole European bone densitometry equipment manufacturer, DMS Group maintains a unique position against North American and South Korean competitors, achieving €11 million in revenue in 2025 with an 8% growth rate.

Following this achievement, DMS Group has filed a pre-submission with the U.S. FDA for its bone densitometers, aiming to enter the US market, which represents nearly 40% of global demand. The company's radiology solutions have been successful in North America, with regional sales up by 71% in 2025.

In addition, DMS Group is seeking MDR certification for its new ONYX mobile radiology system, which is expected in 2026. This development aligns with the group's strategy to enhance its medical imaging offerings and support healthcare institutions' needs for flexible imaging solutions.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all DIAGNOSTIC MEDICAL news